171 related articles for article (PubMed ID: 66869)
21. Pulmonary reactions to drugs.
Lippmann M
Med Clin North Am; 1977 Nov; 61(6):1353-67. PubMed ID: 72895
[TBL] [Abstract][Full Text] [Related]
22. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
23. Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Levantine A; Almeyda J
Br J Dermatol; 1974 Feb; 90(2):239-42. PubMed ID: 4132051
[No Abstract] [Full Text] [Related]
24. Pulmonary toxicity due to bleomycin. Report of a case.
Krous HF; Hamlin WB
Arch Pathol; 1973 Jun; 95(6):407-10. PubMed ID: 4121790
[No Abstract] [Full Text] [Related]
25. [Drug-induced changes in the lungs].
Bargon G
Rontgenblatter; 1984 Jul; 37(7):261-5. PubMed ID: 6205436
[TBL] [Abstract][Full Text] [Related]
26. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced pulmonary disease.
Rosenow EC; Limper AH
Semin Respir Infect; 1995 Jun; 10(2):86-95. PubMed ID: 7569403
[TBL] [Abstract][Full Text] [Related]
28. Bleomycin: pulmonary toxicity.
Rudders RA
Ann Intern Med; 1973 Apr; 78(4):618. PubMed ID: 4121001
[No Abstract] [Full Text] [Related]
29. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
Real E; Roca MJ; Viñuales A; Pastor E; Grau E
Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
[No Abstract] [Full Text] [Related]
30. [Diffuse pneumopathy during chemotherapy with busulfan and bleomycin].
Jeanmart L; Klastersky J; Verhest A; Debusscher L; Potvliege P; Tagnon H; Tombroff M
J Belge Radiol; 1972; 55(4):425-33. PubMed ID: 4118163
[No Abstract] [Full Text] [Related]
31. Late pulmonary toxicity of bleomycin.
Willenbacher W; Mumm A; Bartsch HH
J Clin Oncol; 1998 Sep; 16(9):3205. PubMed ID: 9738596
[No Abstract] [Full Text] [Related]
32. Hepatic and pancreatic damage produced by cytotoxic drugs.
Woolley PV
Cancer Treat Rev; 1983 Jun; 10(2):117-37. PubMed ID: 6223696
[No Abstract] [Full Text] [Related]
33. [Cytostatic agent induced lung disease].
Obrist R; Obrecht JP
Dtsch Med Wochenschr; 1978 May; 103(18):765-6. PubMed ID: 77216
[No Abstract] [Full Text] [Related]
34. Fatal pulmonary toxicity after a single dose of cyclophosphamide.
Gupta S; Mahipal A
Pharmacotherapy; 2007 Apr; 27(4):616-8. PubMed ID: 17381391
[TBL] [Abstract][Full Text] [Related]
35. Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.
Jaffe N
Pediatr Clin North Am; 1976 Feb; 23(1):233-44. PubMed ID: 768885
[No Abstract] [Full Text] [Related]
36. [Drug-induced pulmonary diseases: diagnostic, therapeutic and prognostic aspects. Apropos of 10 personal case reports].
Chabot F; Aymard B; Lesur O; Kheir A; Moreau L; Cornette A; Gerard H; Delorme N; Polu JM
Rev Mal Respir; 1992; 9(6):593-601. PubMed ID: 1281922
[TBL] [Abstract][Full Text] [Related]
37. Bleomycin and pulmonary screening: many questions, few answers.
Duncan CN
Pediatr Blood Cancer; 2014 Sep; 61(9):1527-8. PubMed ID: 24810221
[No Abstract] [Full Text] [Related]
38. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723
[TBL] [Abstract][Full Text] [Related]
39. Acute bleomycin lung.
Perez-Guerra F; Harkleroad LE; Walsh RE; Costanzi JJ
Am Rev Respir Dis; 1972 Dec; 106(6):909-13. PubMed ID: 4118373
[No Abstract] [Full Text] [Related]
40. Pulmonary toxicity of antineoplastic agents.
Green MR
West J Med; 1977 Oct; 127(4):292-8. PubMed ID: 72457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
